Statistics for SKYSCRAPER-02: Primary Results of A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab (Atezo) Plus Carboplatin Plus Etoposide (CE) with or Without Tiragolumab (tira) in Patients (pts) With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC).
Total visits
| views | |
|---|---|
| SKYSCRAPER-02: Primary Results of A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Atezolizumab (Atezo) Plus Carboplatin Plus Etoposide (CE) with or Without Tiragolumab (tira) in Patients (pts) With Untreated Extensive-Stage Small Cell Lung Cancer (ES-SCLC). | 1 |
Total visits per month
| views | |
|---|---|
| September 2025 | 0 |
| October 2025 | 0 |
| November 2025 | 0 |
| December 2025 | 0 |
| January 2026 | 0 |
| February 2026 | 1 |
| March 2026 | 0 |